[HTML][HTML] Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

S Gillessen, G Attard, TM Beer, H Beltran, A Bossi… - European urology, 2018 - Elsevier
Background In advanced prostate cancer (APC), successful drug development as well as
advances in imaging and molecular characterisation have resulted in multiple areas where …

[HTML][HTML] Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019

S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell… - European urology, 2020 - Elsevier
Background Innovations in treatments, imaging, and molecular characterisation in advanced
prostate cancer have improved outcomes, but there are still many aspects of management …

[HTML][HTML] Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021

S Gillessen, A Armstrong, G Attard, TM Beer, H Beltran… - European urology, 2022 - Elsevier
Background Innovations in treatments, imaging, and molecular characterisation in advanced
prostate cancer have improved outcomes, but various areas of management still lack high …

[HTML][HTML] Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer …

S Gillessen, A Bossi, ID Davis, J de Bono… - European journal of …, 2023 - Elsevier
Background Innovations in imaging and molecular characterisation together with novel
treatment options have improved outcomes in advanced prostate cancer. However, we still …

[HTML][HTML] Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of …

S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi… - European urology, 2023 - Elsevier
Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …

[HTML][HTML] Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) …

S Gillessen, A Omlin, G Attard, JS De Bono… - Annals of …, 2015 - Elsevier
ABSTRACT The first St Gallen Advanced Prostate Cancer Consensus Conference (APCCC)
Expert Panel identified and reviewed the available evidence for the ten most important areas …

Updates to advanced prostate cancer: AUA/SUO guideline (2023)

W Lowrance, R Dreicer, DF Jarrard… - The Journal of …, 2023 - auajournals.org
Purpose: In 2022 the American Urological Association (AUA) requested an Update
Literature Review (ULR) to incorporate new evidence generated since the 2020 publication …

Advanced prostate cancer: AUA/ASTRO/SUO guideline part I

WT Lowrance, RH Breau, R Chou, BF Chapin… - The Journal of …, 2021 - auajournals.org
Purpose: The summary presented herein represents Part I of the two-part series dedicated to
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and …

Navigating the evolving therapeutic landscape in advanced prostate cancer

ED Crawford, D Petrylak, O Sartor - Urologic Oncology: Seminars and …, 2017 - Elsevier
Prostate cancer is the most common cause of cancer in men, with 137.9 new cases per
100,000 men per year. The overall 5-year survival rate for prostate cancer is very high. Up to …

EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer

P Cornford, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …